News | April 29, 2023
TPAG organizes Thalassemia & SCD prevention discussion
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
The divested brands include Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands
Point-of-Care solution to facilitate clinicians in quick and effective decision making
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
LG Chem will receive totaling up to $95.5 million for the China rights
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Subscribe To Our Newsletter & Stay Updated
